2018
DOI: 10.1007/s41779-018-0239-7
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced in vivo biocompatibility of magnesia-contained bioactive glasses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…The coexistence of sodium and magnesium in SNCMP glass has dual importance since it enhanced bioactivity and hindered the crystallisation of the Na2Ca2Si3O9 phase at 600°C, which would be beneficial for sintering at higher temperature. Arepalli et al reported that bioactive glasses in the system (46.10-x)%SiO2-26.9%CaO-24.40%Na2O-xMgO-2.6%P2O5 (where 0≤x≤3 mol %) are bioactive and biocompatible both in vitro and in vivo 14,24 . It is well reported that magnesium slows down the crystallization of the apatite layer 16,17 , however, in this work we report the formation of an apatitelike phase after 1 h of soaking in SBF as it can be seen in Figure 3.…”
Section: Resultsmentioning
confidence: 99%
“…The coexistence of sodium and magnesium in SNCMP glass has dual importance since it enhanced bioactivity and hindered the crystallisation of the Na2Ca2Si3O9 phase at 600°C, which would be beneficial for sintering at higher temperature. Arepalli et al reported that bioactive glasses in the system (46.10-x)%SiO2-26.9%CaO-24.40%Na2O-xMgO-2.6%P2O5 (where 0≤x≤3 mol %) are bioactive and biocompatible both in vitro and in vivo 14,24 . It is well reported that magnesium slows down the crystallization of the apatite layer 16,17 , however, in this work we report the formation of an apatitelike phase after 1 h of soaking in SBF as it can be seen in Figure 3.…”
Section: Resultsmentioning
confidence: 99%
“…If the problem is due to drug, disease, or life style, it is resolved by the pharmacist himself. Hand book of Pharmaceutical Care by WHO-FIP is advocating the implementation of pharmaceutical [14][15][16] care as a system of health care delivery.…”
Section: Pharmaceutical Career-a Patient Carementioning
confidence: 99%